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Yeast. 2019;36:237–247.Abstract
The yeast Saccharomyces cerevisiae is widely used in industrial biotechnology for the
production of fuels, chemicals, food ingredients, food and beverages, and pharmaceu-
ticals. To obtain high‐performing strains for such bioprocesses, it is often necessary
to test tens or even hundreds of metabolic engineering targets, preferably in combina-
tions, to account for synergistic and antagonistic effects. Here, we present a method
that allows simultaneous perturbation of multiple selected genetic targets by combin-
ing the advantage of CRISPR/Cas9, in vivo recombination, USER assembly and RNA
interference. CRISPR/Cas9 introduces a double‐strand break in a specific genomic
region, where multiexpression constructs combined with the knockdown constructs
are simultaneously integrated by homologous recombination.
We show the applicability of the method by improving cis,cis‐muconic acid produc-
tion in S. cerevisiae through simultaneous manipulation of several metabolic engineer-
ing targets.
The method can accelerate metabolic engineering efforts for the construction of
future cell factories.
KEYWORDS
cis,cis‐muconic acid, CRISPR/Cas9, genome editing, metabolic engineering, RNA interference,
USER (uracil‐specific excision reagent), Saccharomyces cerevisiae1 | INTRODUCTION
Industrial biotechnology uses cell factories to produce therapeutical
proteins, antibiotics, enzymes, fuels, and chemicals. To achieve favor-
able process economics, one needs to optimize the cell factories,
where performance metrics as titer, rate, and yield are improved.
Strain development programs for the products that are not native
to the host are very costly and take a long time. The required- - - - - - - - - - - - - - - - - - - - - - - - - -
Creative Commons Attribution Li
y & Sons Ltdinvestment in biotechnology companies that develop novel strains
and processes is typically above $50 Mio. During the strain develop-
ment, hundreds to thousands of strain variants are engineered in
iterative design‐build‐test cycles. High‐throughput strain construc-
tion and screening in the range of 105–106variants are possible
when a biosensor indicating the product presence is available
(Zhang, Jensen, & Keasling, 2015); however, this is seldom the case.
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formations. The cloning and strain construction is typically per-
formed at 10–50‐μl scale, where the high cost of specialized
reagents also contributes to the high price of the strain
development.
Metabolic engineering research requires tools for multiplex
genome editing that would allow simultaneous upregulation and
downregulation of multiple genes in a combinatorial way. Clustered
regularly interspaced short palindromic repeats system with associ-
ated nuclease Cas9 (CRISPR/Cas9) system has dramatically simplified
genome editing in yeasts, particularly for performing gene overex-
pression, mutations, and deletions (Lian, HamediRad, & Zhao, 2018;
Stovicek, Holkenbrink, & Borodina, 2017). Convenient CRIPSR/Cas‐
based genetic tools have been developed for Saccharomyces
cerevisiae that enable integration of several gene expression cas-
settes into multiple locior simultaneous deletion of multiple genes
in a single transformation (Bao et al., 2014; Generoso, Gottardi,
Oreb, & Boles, 2016; Horwitz et al., 2015; Jakočiūnas et al., 2015;
Ryan et al., 2014; Verwaal, Buiting‐Wiessenhaan, Dalhuijsen, &
Roubos, 2018). The CRISPR/Cas systems are efficient in editing
not only haploid laboratory strains but also diploid and polyploid
strains of S. cerevisiae important for brewing and bioethanol applica-
tions (Denby et al., 2018; Lian, Bao, Hu, & Zhao, 2018; Stovicek,
Borodina, & Forster, 2015). It has also been illustrated in multiple
studies how overexpressions, deletions, and mutations can be per-
formed in a single transformation (Jakočiu
_
nas et al., 2015; Lian,
HamediRad, Hu, & Zhao, 2017; Mans et al., 2015).
Controlled downregulation of gene expression, however, remains a
challenge. Gene downregulation is often a more desirable metabolic
engineering strategy than complete gene inactivation, and, in case of
essential genes, the only option. Catalytically inactivated dCas9, also
in a variant coupled to a transcriptional repressor, has been applied
for downregulation, but typically multiple gRNA binding sites need
to be tested to obtain the desired repression level (Deaner & Alper,
2017; Jensen et al., 2017; Zalatan et al., 2015). Alternatively, RNA
interference (RNAi) has been demonstrated to allow more precise con-
trol of gene downregulation (Crook, Schmitz, & Alper, 2013;
Drinnenberg et al., 2009; Si, Luo, Bao, & Zhao, 2014; Suk et al., 2011).
In this study, we aimed to develop a method that would allow mul-
tiplex upregulation and downregulation of several genes by combining
the advantages of the CRISPR/Cas9 system and RNAi. The level of
upregulation and downregulation can be tuned by selecting promoters
of different strengths. To illustrate the applicability of the method, we
optimized the cell for production of a prospective chemical molecule
cis,cis‐muconic acid (CCM).2 | MATERIALS AND METHODS
2.1 | Strains, media, and chemicals
S. cerevisiae CEN.PK strains used in this study are listed in Table S1.
The strain of Naumovozyma castellii CLIB290 was received fromCentre International de Ressources Microbiennes, Institut National
de la Recherche Agronomique (INRA), France. Yeast strains were
grown in synthetic complete (SC) medium, synthetic drop‐out (SD)
medium, defined mineral medium or synthetic fed‐batch medium Sc.
syn‐1000 (M2P labs GmbH, Germany) at 30°C. SC and SD media
and agar plates were prepared using premixed drop‐out powders from
Sigma‐Aldrich. The defined mineral medium was prepared as
described previously (Jensen et al., 2014). Escherichia coli strain
DH5α was used as a host for plasmid propagation. E. coli cells were
grown at 37°C in Luria–Bertani medium containing 100 μg ml−1 ampi-
cillin. The chemicals were obtained, if not indicated otherwise, from
Sigma‐Aldrich. Nourseothricin was obtained fromWERNER BioAgents
GmbH (Germany). Phusion U Hot Start DNA polymerase and
PhusionHot Start II DNA polymerase were purchased from Thermo
Fisher Scientific.2.2 | Biobricks amplification and plasmids
construction
The oligonucleotides, biobricks, and plasmids used in this study are
listed in Tables S2, S3, S4, and S5, respectively. Oligonucleotides were
synthesized by Integrated DNA Technologies, Inc (Leuven, Belgium).
A plasmid containing Cas9 and gRNA plasmid for targeting CAN1.Y
locus was obtained from Addgene (DiCarlo et al., 2013).
The genes AGO1 and DCR1 that encode correspondingly for the
Argonaute and Dicer proteins were amplified from genomic DNA of
Naumovozyma castellii. The genes, encoding Klebsiella pneumoniae
KpAroY.B (AAY57854.1), KpAroY.D (AAY57856.1), KpAroY.Ciso
([BAH20873.1], Candida albicans CaCatA (XP_722784.1), and
Podospora anserina PaAroZ (XP_001905369) were synthesized by
GeneArt (Life Technologies) in versions codon‐optimized for
S. cerevisiae. KpAroY.B and KpAroY.D encode B and D subunits of the
protocatechuic acid decarboxylase (PCA‐DC), whereas KpAroY.Ciso
encodes an isoform of subunit C of PCA‐DC. CaCatA encodes the cat-
echol 1,2‐dioxygenase (CDO), and PaAroZ encodes the
dehydroshikimate dehydratase (3‐DHDS). Plasmids expressing
CaCatA, PaAroZ, KpAroY. B, KpAroY.D, and KpAroY. Ciso were previ-
ously constructed and described in Skjoedt et al. (2016). TKL1 encodes
the enzyme transketolase from S. cerevisiae. ZWF1 and ARO1ΔaroE
genes were from S. cerevisiae. The S. cerevisiae aro4K229L encoded a
feedback‐resistant 3‐deoxy‐D‐arabino‐heptulosonate‐7‐phosphate
(DAHP) synthase with an amino acid change Aro4pK229L. The gene
was as described in Rodriguez, Kildegaard, Li, Borodina, and Nielsen
(2015).
All DNA fragments (Table S4) were amplified by PCR using Phusion
U Hot Start DNA Polymerase (Thermo Fisher Scientific) with primers
containing suitable overhangs for USER‐cloning and templates as
described in Tables S2 and S3. The amplified products were cloned
along with strong constitutive promoters into EasyClone integrative
plasmids by USER cloning (Jensen et al., 2014). DNA manipulations
in E. coli were carried out according to standard procedures. The
clones with correct inserts were identified by colony PCR, and the
KILDEGAARD ET AL. 239plasmids were isolated from overnight E. coli cultures and confirmed
by sequencing. The list of the constructed vectors can be found in
Table S5.
For the construction of overexpression cassettes for in vivo assem-
bly, there are five part types in our assembly standard (promoters,
genes, terminators, upstream homology arm, and downstream homol-
ogy arm). The specific overhangs flanking individual parts were
designed and introduced at 5′ end of the forward and reverse primers
as described in Table S3. All DNA parts were PCR amplified using
Phusion U DNA polymerase according to the manufacturer's instruc-
tions. DNA fragments were gel purified and were assembled by con-
secutive procedures of USER reaction, T4 ligation, and PCR
amplification of the assembled expression cassettes as follows: 17 μl
of gel‐purified DNA fragments containing similar molar ratio of all
parts was mixed with 2 μl of CutSmartTM buffer and 1 μl of USER
enzyme (New England BioLabs). The mixes were incubated for
25 min at 37°C followed by 10 min at 25°C. After USER reaction
was complete, 1 μl of T4 ligase, 3 μl of ligase buffer, and 6 μl of water
were added. The mix was incubated for 5 min at room temperature.
Two to three microliter of this ligation mix were used as a template
for the final PCR reaction in order to amplify the whole expression
cassette. The fragments were purified from the gel and used for yeast
transformation (0.7 pmoles per transformation). For fragments smaller
than 500 BP, ca. 2 pmoles of the fragment were used per
transformation.2.3 | Construction of shRNAs
The small hairpin RNA (shRNA) constructs were composed of two
DNA fragments. The first fragment contained approximately 250 BP
sense sequence of the target gene under the control of the constitu-
tive promoter and an 81‐BP sequence spanning intron 1 from
Schizosaccharomyces pombe rad9. The second fragment contained
the antisense sequence of the target gene together with terminator
and an 81‐BP sequence of intron 1 from S. pombe rad9. Sense, anti‐
sense, promoter, and terminator fragments were amplified by PCR.
The corresponding fragments for generating sense and antisense cas-
settes were assembled via USER‐ligation‐PCR as described above. The
intron sequence was implemented in the primer overhang.
Sense and antisense DNA fragments were introduced together
with UP‐ and DW‐fragments for CAN‐1 and were assembled into
the genome of S. cerevisiae at CAN‐1 locus via homologous
recombination.2.4 | Construction of dsRNA
To generate double‐stranded RNA (dsRNA) constructs, the target
gene was PCR amplified and assembled with PGK1p and TEF1p pro-
moters, and ADH1t and RPM9t terminators in convergent direction
via USER‐ligation‐PCR as above.2.5 | Yeast strains construction
All strains used in this study are listed inTable S1. The integrative plas-
mids were NotI‐linearized and transformed into S. cerevisiae cells using
the lithium acetate protocol (Gietz & Woods, 2002). The cells were
selected on SD medium selecting for URA, HIS, LEU and TRP markers.
For the selection of strains carrying KanMXsyn and CloNatMXsyn, the
ammonium sulfate in the SD medium was replaced with 1 g L−1
monosodium glutamate. The medium was supplemented with
200 μg ml−1 G418 sulfate and 100 μg ml−1 nourseothricin. The correct
transformants were confirmed by PCR using primers described in Sup-
plementary Table S2.2.6 | Single cell measurements of fluorescence
Colonies of S. cerevisiae strains to be tested were inoculated into 24
deep‐well plates (EnzyScreen, NL) containing 2‐ml SC medium at
30°C with 300 rpm. After approximately 24 hr, the cells were har-
vested and washed twice with water. The cell pellet was resuspended
in 1 ml of phosphate‐buffered saline buffer. Cells were analyzed on
BD FACSAria equipped with three solid‐state diode lasers: air‐cooled
Coherent™ Sapphire™ solid‐state diode laser (488 nm, 100 mW), air‐
cooled Coherent™ Yellow Green laser (561 nm, 100 mW), and an
air‐cooled Coherent™ Deep Blue laser (445 nm, 50 mW). The follow-
ing filters were used: FITC‐A, PE‐Cy5‐A, and mCFP‐A for the analysis
of emission from yellow fluorescent proteins (YFP), red fluorescent
proteins (RFP), and cyan fluorescent proteins (CFP), respectively.
Compensation was performed according to the manufacturer's proto-
col (BD FACSAria II User's Guide).
Flow cytometry data were analyzed and interpreted using FlowJo
software.2.7 | Muconic acid production in S. cerevisiae
At least 12 single colonies of each transformant were cultivated in 24‐
well plate with air‐penetrable lids (EnzyScreen, NL) to test for the pro-
duction of CCM. The colonies were inoculated in 1‐ml SD medium
without uracil, histidine, and leucine and grown at 30°C with
250 rpm agitation at 5‐cm orbit cast for 24 hr; 300 μl of the overnight
culture was used to inoculate 3 ml of defined mineral medium (pH 6.0)
in 24‐deep well plate and incubated for 72 hr at the same conditions
as above. Experiments were done in triplicates. At the end of the cul-
tivation, OD600 was measured in microplate reader BioTek Synergy
MX (BioTek). The culture broth was spun down at 3,500 g, and the
supernatant was analyzed for CCM concentration using High‐perfor-
mance liquid chromatography (HPLC).2.8 | Quantification of CCM and its intermediates by
HPLC
The samples were diluted five times with water and then analyzed for
45 min using Aminex HPX‐87H ion exclusion column with eluent 1‐
240 KILDEGAARD ET AL.mM H2SO4 flow of 0.6 ml min
−1. The temperature of the column was
60°C. The UV detector (Dionex) was used for detection of CCM
(250 nm), PCA (220 nm), and catechol (220 nm). CCM, PCA, and cate-
chol concentrations were quantified by comparison with the standard
calibration curve.
2.9 | qRT‐PCR analysis
The expression level of ZWF1 in recombinant yeast strains was deter-
mined by quantitative real‐time PCR (qRT‐PCR). Samples for RNA iso-
lation were taken from the cells grown in the mineral medium for
24 hr in triplicates. Sampling procedure and total RNA extraction were
performed as previously described (Kildegaard et al., 2014). The first
strand cDNA synthesis was performed using Oligo (dt)12–18 Primer
and SuperScript™ II Reverse Transcriptase from Invitrogen following
the manufacturer's manual. qRT‐PCR analysis of cDNA was carried
out in triplicate using Brilliant III Ultra‐Fast SYBR® Green QPCR Mas-
ter Mix (Agilent Technologies) on a Stratagene Mx3005P (Agilent
Technologies). The reactions were performed in 20‐μl final volume
with 10 μl of 2x SYBR Green QPCR master mix, 0.5 μl of each
upstream and downstream primers, 0.3 μl of reference dye, 2 μl of
cDNA template (10 ng), and 6.7 μl of nuclease‐free PCR‐grade water.
The thermal cycling conditions were 95°C, 10 min followed by
40 cycles of 95°C for 20 sec, and 60°C for 22 sec, then 1 cycle of
95°C for 1 min, 55°C for 30 min, and 95°C for 30 sec. The gene copy
numbers were measured relative to that of a housekeeping gene
(ALG9). Oligos used for qRT‐PCR are listed inTable S2.The fold change
in gene expression of ZWF1 was determined by relative quantification,
and the calculations were made using double delta method (ΔΔCt),
where ΔΔCt = (ΔCtE − ΔCtC).
2.10 | Growth test in 96‐well microtiter plates
Precultures were prepared by inoculating a single colony in 0.5 ml
defined mineral medium (pH 6.0) in 96‐deep well plate (Enzyscreen).
The plate was incubated at 30°C with 250 rpm agitation at 5‐cm
orbit cast overnight. Five microliter of the overnight cultures were
inoculated into 150 μl of fresh medium in a new 96‐well flat bottom
plate (Greiner). The plate was sealed with Breathe‐Easy® sealing
membrane (Sigma‐Aldrich) and incubated at 30°C with shaking in
the BioTek ELx808 microplate reader (BioTek), and the absorbance
was measured at 630 nm wavelength every 10 min for 42 hr.
Experiments were done in five biological replicates, and the maxi-
mum specific growth rates were calculated in the exponential
growth phase.3 | RESULTS AND DISCUSSION
3.1 | Validation of the method for simultaneous
expression of multiple genes at different levels
We aimed to develop a method that would allow simultaneous pertur-
bation of multiple genetic targets. For this, we decided to combine theadvantages of CRISPR/Cas9, in vivo recombination, USER assembly,
and RNAi. CRISPR/Cas9 system was used to introduce a double‐
strand break into a specific genome region, then overexpression and
RNAi knock‐down constructs were assembled and integrated into this
genome region by homologous recombination. To enable the assem-
bly, we designed 60 BP synthetic homologous recombination (SHR)
sequences like following. We have used the UPTAG and DNTAG
sequences from yeast knockout libraries to design the SHR sequences.
We recombined 20 BP‐UPTAG and DNTAG sequences from yeast
knock‐out library (Giaever and Nislow 2014) to obtain final sequences
of 60 BP. These sequences were BLASTed against S. cerevisiae genome
to select the sequences with low homology that were used as over-
hang sequences for assembly.
The gene BioBricks included standard 6–8 BP USER overhangs for
easy assembly with promoters and terminators (Figure 1a). The pro-
moter biobricks included standard 18 BP overhang (L1) at the 5′‐end
and 6–8 BP USER overhang at 3′‐end. Similarly, the terminator
biobricks also included standard 6–8 BP USER overhang and 18 BP
overhang (L2) at 5′‐ and 3′‐end, respectively. The standard overhangs
L1 and L2 were combined with the SHR sequences and used as
primers for amplification of the assembled expression cassettes. This
design allows reusing a standard set of primers for amplification of dif-
ferent genes, so the genes can be combined with different
promoter/terminator pair. There is also a standard set of primers for
amplification of expression cassettes that can be combined in the
desired order. We used a range of promoters of different strengths
(Table S2) and terminators. In order to validate the method for
expressing multiple genes, we introduced three fluorescent protein‐
coding genes (CFP, YFP, and RFP) under control of promoters of vary-
ing strength. A S. cerevisiae strain CEN.PK2‐1C (Mata ura3 his3 leu2
trp1) expressing Cas9p (TRP1 selection) was transformed with gRNA
(LEU2 selection) targeting CAN1 site and with three overexpression
cassettes, marker cassette (KlURA3), and up‐ and down‐fragments of
CAN1. The CAN1 site was chosen because it allows easy validation
of correct integration on selective plates, but as such, any site can
be used. For example, intergenic sites reported as EasyClone sites
can be used (Jessop‐Fabre et al., 2016). The selection marker can be
omitted as well if desired; this will, however, lead to a slightly higher
number of nonedited clones. Transformants were selected on drop‐
out plates without tryptophan, leucine, and uracil. The correct integra-
tion into the CAN1 site was investigated by replicating the colonies on
SC‐arg + canavanine plates, where only strains with disrupted CAN1
gene can survive. More than 95% of the colonies could grow on SC‐
arg + can.
Furthermore, multiplex PCR was performed to verify the correct
assembly, at least 70% of the tested strains were correct according
to PCR. The fluorescence levels were evaluated by fluorescent cytom-
etry. The four designed strains expressed all three RFP, CFP, and YFP
proteins at the levels that corresponded to promoter strength
(TDH3p > RPL18Bp > RNR2p; Figure 1b).
In the past few years, several CRISPR/Cas9 mediated multiplex
genome engineering approaches were demonstrated. Mans et al.
(2015) explored the potential of CRISPR/Cas9 to combine gene
FIGURE 1 Method for expression of multiple genes. (a) Overview of the CRISPR/Cas9‐RNA interference workflow for expressing multiple
genes. First, expression constructs are assembled using USER cloning‐ligation‐PCR. The promoter and terminator are chosen to obtain the
desired gene expression level. In the next step, the expression constructs are transformed into Cas9‐expressing yeast strain, along with upstream
and downstream repair fragments and a selective marker. (b) Fluorescent cytometry analysis of four Saccharomyces cerevisiae strains, where genes
encoding for red (RFP), cyan (CFP), and yellow (YFP) fluorescent proteins were expressed under control of promoters with different strengths
[Colour figure can be viewed at wileyonlinelibrary.com]
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integration of multiple DNA fragments. A strain carrying a double
ACS1 and ACS2 deletion combined with six gene cassettes express-
ing the Enterococcus faecalis pyruvate dehydrogenase (PDH) complex
(aceF, lplA2, lplA, pdhB, lpd, and pdhA) was constructed in a single
transformation with 100% efficiency. In another study, Jakočiu
_
nas
et al. (2015) developed CasEMBLR, a tool for highly efficient and
marker‐free assembly and integration of multiple DNA components
into genomic loci. One step assembly and integration of the
carotenoid pathway (CrtYB, CrtI, and CrtE) from 15 DNA parts
(upstream homology arm, promoter, CDS, terminator, and down-
stream homology arm) into three targeted loci (ADE2, HIS3, and
URA3) was demonstrated with the 31% efficiency. Furthermore,
CasEMBLR was also used to assemble and integrate the five‐part
assembly of the ARO4* and ARO7* expression cassettes into genomic
PDC5 and ARO10 loci with an average efficiency of 58%. Our
method is not essentially different from the previous studies but
provides an advantage of standardized design of primer overhangs
and consequently facilitates combinatorial assembly of genes and
promoters/terminators.3.2 | Validation of the method for downregulation of
gene expression using RNAi
RNAi machinery is present in multiple eukaryotes, including some
yeast species, such as Naumovozyma castellii (Crook et al., 2013;
Drinnenberg et al., 2009; Suk et al., 2011). Although S. cerevisiae does
not harbor an active RNAi pathway, this pathway can be restored by
introducing Argonaute (AGO1) and Dicer (DCR1) genes from
Naumovozyma castellii into the genome of S. cerevisiae. In this study,
we sought to reconstitute the RNAi machinery in S. cerevisiae to allow
controlled downregulation of multiple target genes. We first imple-
mented AGO1 and DCR1 from Naumovozyma castellii into S. cerevisiae
through genomic integration and further expressed Cas9 in the
engineered strain from a CEN/ARS plasmid (Figure 2a). For the
proof‐of‐concept, we chose to use fluorescent proteins as a reporter
system. Three fluorescent protein‐encoding genes under control of
strong constitutive promoters were integrated into the genome of
the yeast strain with AGO1/DCR1/Cas9 to obtain strain ST3135 for
testing RNAi.
To test the capability of RNA silencing in S. cerevisiae, we evalu-
ated two different approaches, shRNAs and dsRNAs, to silence CFP
and YFP. Due to the nucleotide sequence homology between CFP
and YFP, we designed shRNA and dsRNA constructs to target both
genes simultaneously. The shRNA constructs contained inverted
repeats of 250‐BP parts of the target gene with a hairpin in between
(Figure 2b). The dsRNA construct contained the target gene flanked
by convergent promoters to generate a dsRNA transcript. Both
silencing constructs were under the control of strong constitutive
promoters. A significant knockdown of CFP/YFP expression was
observed with shRNA construct of CFP/YFP, but not with dsRNAconstruct (Figure 2c). These results confirmed that the RNAi mecha-
nism is functional in S. cerevisiae, and the highest level of RNA
silencing was obtained from hairpin constructs, which was in line
with the previous reports. Drinnenberg et al. (2009) restored the
functional RNAi system in S. cerevisiae by heterologous expression
of AGO1 and DCR1. The two constructs shRNA and dsDNA were
designed to silence a green fluorescent protein (GFP) reporter, and
shRNA has been reported to be the stronger silencing construct
compared with dsRNA, both at RNA and fluorescence levels. Fur-
thermore, Crook et al. (2013) studied several design principles for
the construction of hairpin RNA expression cassettes and reported
that the RNAi efficiency was improved with increasing hairpin length
and demonstrated the effectiveness of RNAi by testing several
genetic targets for improvement of itaconic acid production in three
strains of S. cerevisiae.
In our study, the hairpin length of approximately 250 BP was
used. It should also be noted that in vivo assembly of sense and anti-
sense fragments provides a more straightforward approach to intro-
duce shRNA compared with the cloning of inverted repeats via
restriction‐ligation cloning in E. coli as in Yoshimatsu and Nagawa
(1989).3.3 | Engineering CCM production through multiplex
engineering
In the previous study, we have constructed a S. cerevisiae CCM pro-
ducing strain ST3058 (Skjoedt et al., 2016). ST3058 expresses a
three‐step heterologous pathway consisting of a gene encoding
dehydroshikimate dehydratase (3‐DHS) from Podosporaanserine
(PaAroZ), the genes encoding three different subunits of PCA‐DC
from Klebsiella pneumonia (KpAroY.B, KpAroY.Ciso, KpAroY.D), and
the gene encoding catechol 1,2‐dioxygenase (CDO) from Candida
albicans (CaCatA; Figure 3a). It has been reported that PCA‐DC
was a rate‐limiting step for the CCM flux (Curran, Leavitt, Karim, &
Alper, 2013; Weber et al., 2012). For this reason, we integrated
KpAroY.B and KpAroY.Ciso genes in multiple copies into long 113 ter-
minal repeats (LTRs) of retrotransposon of the TY4 family (Maury
et al., 2016). As the transformants were expected to have different
copy numbers of the expression vector, we screened 12 randomly
selected clones to test for CCM production. The best isolate of
ST3058 produced 400 mg L−1 CCM in defined mineral medium
and was chosen for evaluating the CRISPR/Cas9‐RNAi method. We
implemented Cas9, AGO1, and DCR1 into the best isolate of
ST3058, resulting in strain ST3639 that was suitable for testing
our method.
For the test, we designed to vary the expression of four native
genes that could influence the CCM flux: TKL1 encoding
transketolase, ARO4K229L encoding tyrosine‐feedback‐resistant allele
of phospho‐2‐dehydro‐3‐deoxyheptonate aldolase, ARO1ΔaroE
encoding a pentafunctional AROM protein ARO1 without the dehy-
drogenase domain AROE, and ZWF1 encoding glucose‐6‐phosphate
FIGURE 2 Method for downregulation of target genes. (a) Two heterologous genes AGO1 and DCR1 from Naumovozyma castellii were
overexpressed in a yeast strain already expressing Cas9 and CFP‐YFP‐RFP genes. (b) Schematic illustration of USER assembly of the
downregulation cassette. (c) Fluorescence images of yeast colonies expressing either individual fluorescent proteins, three fluorescent proteins
(XFP), or expressing XFPs, and a downregulation construct for CFP/YFP [Colour figure can be viewed at wileyonlinelibrary.com]
KILDEGAARD ET AL. 243dehydrogenase (Figure 3b). We generated seven strain variants that
carried overexpressions of either TKL1, ARO4K229L, ARO1ΔaroE or
downregulations of ZWF1, or a combination of overexpressions and
downregulation. For verification of correct assembly and integration,
multiplex PCR of a minimum of 12 colonies per transformation was
used. On the basis of genotyping, we obtained engineering efficien-
cies of at least 85% for in vivo assembly and integration of three
DNA fragments (upstream homology arm, single expression cassette,
and downstream homology arm), whereas 55% efficiency was
obtained for combinatorial multiplex genome integration of seven
DNA fragments. Several strain variants, that is, strains with downreg-
ulation of ZWF1, had higher CCM titer and specific yield than the
parental strain ST3639. The improvement in CCM production in the
engineered strains was more pronounced on feed‐in‐time mediumsimulating carbon‐limited fed‐batch conditions than in a standard
batch medium. Overexpression of either TKL1 or ARO1ΔaroE and
downregulation of ZWF1 with either strong or weak promoter
(TDH3p and RNR2p) improved the titer by 5–21%, and the specific
yield by 11–60% when the strains were grown on feed‐in‐time
medium (Figure 3c,d). Contrary, overexpression of the ARO4K229L
gene had no positive effect on CCM titer and yield. We also mea-
sured the μmax of the four strains with ZWF1 downregulation. No sig-
nificant difference was observed in the ZWF1 downregulation strains
in comparison with the reference strain (Figure S1). However, ZWF1
downregulation did result in a reduction of the biomass yield in com-
parison with the reference strain. This observation might explain the
significant improvement in specific CCM yield in strains with down-
regulation of ZWF1 (TDH3p). The downregulation of ZWF1 gene
FIGURE 3 Application of CRISPR/Cas9‐RNA interference method for engineering cis,cis‐muconic acid production in Saccharomyces cerevisiae. (a)
Muconic biosynthesis pathway in yeast. (b) Schematic illustration of the seven‐part assembly of the three overexpression cassettes for TKL1,
ARO4K229L, ARO1ΔaroE, one downregulation cassette of ZWF1, and homologous recombination with chromosomal target site CAN1. (c, d) Average
cis,cis‐muconic acid titers and yields, respectively, in the parent strain ST3639 and engineered strains with either expression of TKL1, ARO4K229L,
ARO1ΔaroE, downregulation of ZWF1 or multiplex expression of all combinations. Cultivations were performed in biological triplicates, and error
bars represent the standard deviation of the average (n = 3). (e) qRT‐PCR analyses. Fold change in gene expression of engineered strains compared
with the parent strain ST3639. ↑ indicates that a gene was expressed in a copy, ↑↑ indicates that a gene was expressed in several copies, ↓
indicates downregulation of ZWF1 under control of either TDH3p or RNR2p promoters. Error bars represent the standard deviation of duplicates
[Colour figure can be viewed at wileyonlinelibrary.com]
244 KILDEGAARD ET AL.
KILDEGAARD ET AL. 245was investigated by qRT‐PCR (Figure 3e). In the strain, where the
only implemented modification was ZWF1 downregulation, the
expression level decreased by 80% or 95% when weak and strong
promoters were driving shRNA expression, respectively. In the strain,
where additional three genes were overexpressed, the downregula-
tion of ZWF1 was at 35% or 55%, again depending on the promoter
for shRNA. The positive effects of TKL1 overexpression and ZWF1
downregulation on CCM production are in agreement with a previous
report, where ZWF1 was though deleted rather than downregulated
(Curran et al., 2013; Weber et al., 2012). Both genes are involved in
the pentose phosphate pathway, and the modification of their
expression possibly improved the supply of the aromatic amino acids
precursor—erythrose 4‐phosphate. The positive effects of these mod-
ifications need to be further confirmed in fed‐batch fermentations in
controlled bioreactors.
In the past few years, there has been a growing interest in applying
CRISPR methods for combinatorial metabolic engineering. Vanegas,
Lehka, and Mortensen (2017) developed a Cas9/dCas9 based system,
SWITCH, which allows S. cerevisiae strains to alternate between a
genetic engineering state and a pathway control state. The Cas9 sys-
tem was first used in the genetic engineering state to implement the
five genes necessary for naringenin production into the chromosome.
Next, the cells were switched to pathway control state by replacing
the Cas9 expression cassette with dCas9 expression cassette. At this
state, the naringenin production was further optimized by dCas9‐
mediated downregulation of an essential gene TSC13 to prevent for
formation of a by‐product. However, the SWITCH approach only
allows the cells to be in either a genetic engineering or a pathway con-
trol state at a time.
In another study, Lian et al. (2017) developed a trifunctional
CRISPR system that combines one nuclease‐deficient CRISPR protein
fused with an activation domain for transcriptional activation
(CRISPRa), a second nuclease‐deficient CRISPR protein fused with a
repression domain for transcriptional interference (CRISPRi), and a
third catalytically active CRISPR protein for gene deletion (CRISPRd)
in the same cells. Lian et al. characterized several CRISPR orthologs
in S. cerevisiae and further optimized for transcriptional regulation by
engineering the corresponding effector domains. The optimal design
of the trifunctional CRISPR system was using nuclease‐deficient
Cpf1 from Lachnospiraceae bacterium (dLbCpf1‐VP) for CRISPRa,
nuclease‐deficient Cas9 from Streptococcus pyogenes (dSpCas9‐
RD1153) for CRISPRi, and Cas9 from Staphylococcus aureus (SaCas9)
for CRISPRd. As a proof‐of‐ concept, the trifunctional CRISPR system
was used to increase β‐carotene production via simultaneous upregu-
lation of HMG1, downregulation of ERG9, and deletion of ROX1. Fur-
thermore, 2.5‐fold improvement in the display of an endoglucanase
on the yeast surface was obtained by combinatorial optimization of
several metabolic targets. At this point, the selection of efficient gRNA
for CRISPRi remains a challenge and multiple variants need to be
tested. This increases the number of strains that need to be con-
structed for testing downregulation targets or combinations of down-
regulation targets with overexpression targets.During this work, a study was published by Si et al. (2017) that
reported a combination of RNAi and CRISPR/Cas9 for constructing
S. cerevisiae strains with overexpressions and downregulations. The
authors used δ‐regions for integration of the constructs, and hence
the obtained strains are not defined as in our method but have varying
numbers of different expression/downregulation cassettes integrated.
Si et al. applied dsDNA constructs for RNAi, whereas in our study,
shDNA were shown to be more effective for downregulating gene
expression.
Our method combines the advantages of RNAi for precise down-
regulation, of CRISPR/Cas9 for efficient genomic integration and of
yeast homologous recombination for the multiple fragment assembly.
The method is convenient for testing defined combinations of multiple
upregulation and downregulation targets for metabolic engineering.
The method can facilitate the strain development efforts by increasing
the throughput and decreasing the cost of strain construction. In the
future, it can be further applied for generating combinatorial libraries
of strain variants by using mixes of BioBricks rather than specific
BioBricks. The library approach is particularly attractive if a high‐
throughput method for screening the strain libraries is available, as is
the case with muconic acid, where a biosensor has been reported
(Skjoedt et al., 2016).
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